In this research, CD44-targeted, biotin-targeted, and folate-targeted amphiphilic Bio-oHA-Hyd-FA drug carriers were successfully synthesized for delivery of ICA&Cur to tumor cells and cancer stem cell. Here, CD44 is linked to cancer.